537
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Effect of prebiotic and probiotic supplementation on reduced pain in patients with fibromyalgia syndrome: a double-blind, placebo-controlled randomized clinical trial

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 528-541 | Received 19 Oct 2021, Accepted 16 May 2023, Published online: 24 May 2023

References

  • Aaron, L. A., Burke, M. M., & Buchwald, D. (2000). Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Archives of Internal Medicine, 160(2), 221–227. https://doi.org/10.1001/archinte.160.2.221
  • Agargun, M. (1996). Pittsburgh uyku kalitesi indeksinin gecerligi ve guvenirligi. Turk Psikiyatri Dergisi, 7, 107–115. https://ci.nii.ac.jp/naid/20001210233/
  • Ahmed, W., & Rashid, S. (2019). Functional and therapeutic potential of inulin: A comprehensive review. Critical Reviews in Food Science and Nutrition, 59(1), 1–13. https://doi.org/10.1080/10408398.2017.1355775
  • Beck, A. T., Epstein, N., Brown, G., & Steer, R. (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of consulting and clinical psychology, 56(6), 893–897. https://doi.org/10.1037//0022-006x.56.6.893
  • Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The fibromyalgia impact questionnaire: Development and validation. The Journal of Rheumatology, 18(5), 728–733.
  • Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193–213. https://doi.org/10.1016/0165-1781(89)90047-4
  • Cavalcante, A. B., Sauer, J. F., Chalot, S. D., Assumpção, A., Lage, L. V., Matsutani, L. A., & Marques, A. P. (2006). A prevalência de fibromialgia: uma revisão de literatura. Revista brasileira de reumatologia, 46(1), 40–48. https://doi.org/10.1590/S0482-50042006000100009
  • Chen, X., Zou, K., Abdullah, N., Whiteside, N., Sarmanova, A., Doherty, M., & Zhang, W. (2017). The placebo effect and its determinants in fibromyalgia: Meta-analysis of randomised controlled trials. Clinical Rheumatology, 36(7), 1623–1630. https://doi.org/10.1007/s10067-017-3595-8
  • Clauw, D. J. (2014). Fibromyalgia: A clinical review. Jama, 311(15), 1547–1555. https://doi.org/10.1001/jama.2014.3266
  • Collins, S. M., & Bercik, P. (2009). The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology, 136(6), 2003–2014. https://doi.org/10.1053/j.gastro.2009.01.075
  • Goehler, L. E., Lyte, M., & Gaykema, R. P. (2007). Infection-induced viscerosensory signals from the gut enhance anxiety: Implications for psychoneuroimmunology. Brain, Behavior, and Immunity, 21(6), 721–726. https://doi.org/10.1016/j.bbi.2007.02.005
  • Goetz, C. G., Wuu, J., McDermott, M. P., Adler, C. H., Fahn, S., Freed, C. R., Hauser, R. A., Olanow, W. C., Shoulson, I., Tandon, P., & Leurgans, S. (2008). Placebo response in Parkinson’s disease: Comparisons among 11 trials covering medical and surgical interventions. Movement Disorders, 23(5), 690–699. https://doi.org/10.1002/mds.21894
  • Holmes, R., Tiwari, A., & Kennedy, J. (2016). Mechanisms of the placebo effect in pain and psychiatric disorders. The Pharmacogenomics Journal, 16(6), 491–500. https://doi.org/10.1038/tpj.2016.15
  • Hutkins, R. W., Krumbeck, J. A., Bindels, L. B., Cani, P. D., Fahey, G., Jr., Goh, Y. J., Hamaker, B., Martens, E. C., Mills, D. A., & Rastal, R. A. (2016). Prebiotics: Why definitions matter. Current Opinion in Biotechnology, 37, 1–7. https://doi.org/10.1016/j.copbio.2015.09.001
  • Jackson, M. L., Butt, H., Ball, M., Lewis, D. P., & Bruck, D. (2015). Sleep quality and the treatment of intestinal microbiota imbalance in chronic fatigue syndrome: A pilot study. Sleep Science, 8(3), 124–133. https://doi.org/10.1016/j.slsci.2015.10.001
  • Jia, S., Lu, Z., Gao, Z., An, J., Wu, X., Li, X., Dai, X., Zheng, Q., & Sun, Y. (2016). Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-β1–42-induced rat model of Alzheimer’s disease. International Journal of Biological Macromolecules, 83, 416–425. https://doi.org/10.1016/j.ijbiomac.2015.11.011
  • Kanaan, R. A., Lepine, J. P., & Wessely, S. C. (2007). The association or otherwise of the functional somatic syndromes. Psychosomatic Medicine, 69(9), 855. https://doi.org/10.1097/PSY.0b013e31815b001a
  • Kato-Kataoka, A., Nishida, K., Takada, M., Suda, K., Kawai, M., Shimizu, K., Kushiro, A., Hoshi, R., Watanabe, O., & Igarashi, T. (2016). Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress. Beneficial Microbes, 7(2), 153–156. https://doi.org/10.3920/BM2015.0100
  • Kazemi, A., Noorbala, A. A., Azam, K., & Djafarian, K. (2019). Effect of prebiotic and probiotic supplementation on circulating pro-inflammatory cytokines and urinary cortisol levels in patients with major depressive disorder: A double-blind, placebo-controlled randomized clinical trial. Journal of Functional Foods, 52, 596–602. https://doi.org/10.1016/j.jff.2018.11.041
  • Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017). Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology, 112, 399–412. https://doi.org/10.1016/j.neuropharm.2016.07.002
  • Kocyigit, H. (1999). Reliability and validity of the Turkish version of short form-36 (SF-36): A study in a group of patients will rheumatic diseases. Turk J Drugs Ther, 12, 102–106. https://ci.nii.ac.jp/naid/20000884288/
  • Konieczna, P., Groeger, D., Ziegler, M., Frei, R., Ferstl, R., Shanahan, F., Quigley, E. M., Kiely, B., Akdis, C. A., & O’Mahony, L. (2012). Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: Potential role for myeloid and plasmacytoid dendritic cells. Gut, 61(3), 354–366. https://doi.org/10.1136/gutjnl-2011-300936
  • Lakhan, S. E., & Kirchgessner, A. (2010). Gut inflammation in chronic fatigue syndrome. Nutrition & Metabolism, 7(1), 79. https://doi.org/10.1186/1743-7075-7-79
  • Leith, S., Wheatley, R., Jackson, I., Madej, T., & Hunter, D. (1994). Extradural infusion analgesia for postoperative pain relief. BJA: British Journal of Anaesthesia, 73(4), 552–558. https://doi.org/10.1093/bja/73.4.552
  • Liu, R. T., Walsh, R. F., & Sheehan, A. E. (2019). Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neuroscience & Biobehavioral Reviews, 102, 13–23. https://doi.org/10.1016/j.neubiorev.2019.03.023
  • Logan, A. C., & Katzman, M. (2005). Major depressive disorder: Probiotics may be an adjuvant therapy. Medical Hypotheses, 64(3), 533–538. https://doi.org/10.1016/j.mehy.2004.08.019
  • Logan, A. C., Rao, A. V., & Irani, D. (2003). Chronic fatigue syndrome: Lactic acid bacteria may be of therapeutic value. Medical Hypotheses, 60(6), 915–923. https://doi.org/10.1016/S0306-9877(03)00096-3
  • Lorenzo-Zúñiga, V., Llop, E., Suárez, C., Álvarez, B., Abreu, L., Espadaler, J., & Serra, J. (2014). I. 31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World Journal of Gastroenterology: WJG, 20(26), 8709. https://doi.org/10.3748/wjg.v20.i26.8709
  • Marques, A. P., Do Espírito Santo, A. D. S., Berssaneti, A. A., Matsutani, L. A., & Yuan, S. L. K. (2017). Prevalence of fibromyalgia: Literature review update. Revista brasileira de reumatologia, 57(4), 356–363. https://doi.org/10.1016/j.rbre.2017.01.005
  • Mayer, E. A., Tillisch, K., & Gupta, A. (2015). Gut/Brain axis and the microbiota. Journal of Clinical Investigation, 125(3), 926–938. https://doi.org/10.1172/JCI76304
  • Mirwald, R. L., Baxter-Jones, A. D., Bailey, D. A., & Beunen, G. P. (2002). An assessment of maturity from anthropometric measurements. Medicine & Science in Sports & Exercise, 34(4), 689–694. https://doi.org/10.1249/00005768-200204000-00020
  • Quigley, E. M. (2017). Microbiota-brain-gut axis and neurodegenerative diseases. Current Neurology and Neuroscience Reports, 17(12), 94. https://doi.org/10.1007/s11910-017-0802-6
  • Rao, A. V., Bested, A. C., Beaulne, T. M., Katzman, M. A., Iorio, C., Berardi, J. M., & Logan, A. C. (2009). A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens, 1(1), 1–6. https://doi.org/10.1186/1757-4749-1-6
  • Roman, P., Carrillo-Trabalon, F., Sanchez Labraca, N., Cañadas, F., Estevez, A., & Cardona, D. (2018). Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review. Beneficial Microbes, 9(4), 603–611. https://doi.org/10.3920/BM2017.0125
  • Roman, P., Estévez, A. F., Miras, A., Sánchez-Labraca, N., Cañadas, F., Vivas, A. B., & Cardona, D. (2018). A pilot randomized controlled trial to explore cognitive and emotional effects of probiotics in fibromyalgia. Scientific Reports, 8(1), 1–9. https://doi.org/10.1038/s41598-018-29388-5
  • Sarmer, S., Ergin, S., & Yavuzer, G. (2000). The validity and reliability of the Turkish version of the fibromyalgia impact questionnaire. Rheumatology International, 20(1), 9–12. https://doi.org/10.1007/s002960000077
  • Savignac, H. M., Couch, Y., Stratford, M., Bannerman, D. M., Tzortzis, G., Anthony, D. C., & Burnet, P. W. (2016). Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice. Brain, Behavior, and Immunity, 52, 120–131. https://doi.org/10.1016/j.bbi.2015.10.007
  • Sawada, D., Kawai, T., Nishida, K., Kuwano, Y., Fujiwara, S., & Rokutan, K. (2017). Daily intake of Lactobacillus gasseri CP2305 improves mental, physical, and sleep quality among Japanese medical students enrolled in a cadaver dissection course. Journal of Functional Foods, 31, 188–197. https://doi.org/10.1016/j.jff.2017.01.042
  • Theoharides, T. C., Tsilioni, I., Arbetman, L., Panagiotidou, S., Stewart, J. M., Gleason, R. M., & Russell, I. J. (2015). Fibromyalgia syndrome in need of effective treatments. Journal of Pharmacology and Experimental Therapeutics, 355(2), 255–263. https://doi.org/10.1124/jpet.115.227298
  • Tuğlu, C., Türe, M., Dağdeviren, N., & Aktürk, Z. (2007). Birinci basamak için beck depresyon tarama ölçeği’nin türkçe çevriminin geçerlik ve güvenirliği. Türkiye Aile Hekimliği Dergisi, 9(3), 117–122.
  • Wall, R., Cryan, J. F., Ross, R. P., Fitzgerald, G. F., Dinan, T. G., & Stanton, C. (2014). Bacterial neuroactive compounds produced by psychobiotics. Advances in Experimental Medicine and Biology, 817, 221–239. https://doi.org/10.1007/978-1-4939-0897-4_1
  • Ware, J. E., Jr. (2000). SF-36 health survey update. Spine, 25(24), 3130–3139. https://doi.org/10.1097/00007632-200012150-00008
  • Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010). The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research, 62(5), 600–610. https://doi.org/10.1002/acr.20140

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.